What is the appropriate acute management plan for a 54‑year‑old patient presenting with substantial chest pain suggestive of acute coronary syndrome?

Immediate Management Plan for 54-Year-Old with Substantial Chest Pain

This patient requires immediate 12-lead ECG within 10 minutes of presentation to differentiate between STEMI and non-ST-elevation ACS, followed by risk-stratified treatment based on ECG findings and high-sensitivity troponin levels. 1

Initial Assessment & Triage (First 10 Minutes)

Obtain 12-lead ECG immediately to classify the patient into one of two critical pathways 2, 1:

If Persistent ST-Elevation (>20 minutes):

• STEMI pathway: Activate immediate reperfusion strategy
• Primary PCI within 120 minutes reduces mortality from 9% to 7% 3
• If PCI unavailable within 120 minutes: administer fibrinolytic therapy (alteplase, reteplase, or tenecteplase at full dose if <75 years; half dose if ≥75 years) 3

If No Persistent ST-Elevation:

• Proceed with NSTE-ACS evaluation
• ECG may show: transient ST-elevation, ST-depression, T-wave inversion, flat T-waves, pseudo-normalization, or be normal 2
• Draw high-sensitivity cardiac troponin immediately (preferably hs-cTn T or I) 2, 4

Immediate Medical Therapy (All Patients Unless Contraindicated)

Initiate the following immediately while awaiting diagnostic results 2, 5, 2:

1. Aspirin 150-300 mg loading dose (chewed for faster absorption), then 75-100 mg daily 2

2. Oxygen 2-4 L/min if oxygen saturation <90%, breathlessness, or signs of heart failure 6

3. Sublingual nitroglycerin followed by IV nitroglycerin for ongoing chest pain 5

4. Morphine 4-8 mg IV for pain relief (additional 2 mg doses every 5 minutes as needed) 6, 5

5. Anticoagulation: Start unfractionated heparin, low-molecular-weight heparin, fondaparinux, or bivalirudin 7

Risk Stratification for NSTE-ACS

Very High-Risk Features (require immediate invasive strategy <2 hours) 2:

• Hemodynamic instability or cardiogenic shock
• Recurrent/ongoing chest pain refractory to medical treatment
• Life-threatening arrhythmias or cardiac arrest
• Mechanical complications of MI
• Acute heart failure with refractory angina or ST deviation
• Recurrent dynamic ST- or T-wave changes with intermittent ST-elevation

High-Risk Features (require early invasive strategy <24 hours) 2:

• Rise or fall in cardiac troponin compatible with MI
• Dynamic ST- or T-wave changes (symptomatic or silent)
• GRACE score >140

Intermediate-Risk Features (invasive strategy <72 hours) 2:

• Diabetes mellitus
• Renal insufficiency (eGFR <60 mL/min/1.73 m²)
• LVEF <40% or heart failure
• Early post-infarction angina
• Recent PCI or prior CABG
• GRACE score 109-140

Dual Antiplatelet Therapy Selection

Add a P2Y12 inhibitor to aspirin based on the following hierarchy 2:

1. Ticagrelor (180 mg loading, then 90 mg twice daily): Preferred for all moderate-to-high risk patients with elevated troponins, regardless of initial strategy 2

2. Prasugrel (60 mg loading, then 10 mg daily): Use in patients proceeding to PCI only after coronary anatomy is known (contraindicated before angiography) 2

3. Clopidogrel (300-600 mg loading, then 75 mg daily): Reserve for patients who cannot receive ticagrelor/prasugrel or require oral anticoagulation 2

Critical Pitfalls to Avoid

• Do not wait for troponin results to initiate reperfusion in STEMI 6
• Do not administer prasugrel before knowing coronary anatomy 2
• Do not assume normal ECG excludes ACS: 41% of NSTE-ACS patients have neither ST-depression nor T-wave inversion 3
• Do not rely on nitroglycerin response: Relief with nitroglycerin occurs in 35% of ACS patients but also 41% of non-ACS patients 8
• Serial troponin required: Repeat at 1 hour (if using validated 0/1-hour algorithm) or 3-6 hours 4, 9

Ongoing Monitoring

• Continuous cardiac rhythm monitoring for arrhythmia detection 6
• Repeat ECG with any recurrence of chest pain 10
• Echocardiography to assess LV function and rule out mechanical complications 2
• Monitor for hemodynamic instability: hypotension, pulmonary rales, new murmurs 10

Additional Therapies

• Beta-blocker (unless contraindicated by heart failure, bradycardia, or hypotension) 10, 7
• High-intensity statin initiated as early as possible 2
• ACE inhibitor particularly if anterior MI, heart failure, or LVEF <40% 7
• Proton pump inhibitor for patients at high GI bleeding risk on dual antiplatelet therapy 7

The key distinction is ECG-based triage within 10 minutes: persistent ST-elevation mandates immediate reperfusion, while non-ST-elevation requires troponin-based risk stratification to determine timing of invasive strategy.